Tethon 3D, a pioneer in technical ceramic and 3D printing supplies, is coming into the sphere of bioprinting with the launch of a full bioprinting ecosystem. This revolutionary suite consists of the Bison Bio DLP 3D printer, co-developed with high-speed DLP 3D printer producer Carima, alongside Tethon LAP photoinitiator and Tethon GelMA hydrogel bioink, created in partnership with Cell Bark Innovation. This complete providing marks Tethon’s entrance into the bioprinting revolution.
“For over a decade, Tethon 3D has thrived on pushing the boundaries of 3D printing with superior technical ceramic supplies,” stated Tethon 3D Co-founder and Nebraska Drugs CEO James Linder, MD. “We’re thrilled to leverage our experience in a brand new area – bioprinting – and contribute to developments in regenerative drugs.”
Tethon 3D’s foray into bioprinting isn’t a random step. The corporate’s founders, with their medical backgrounds, are deeply dedicated to propelling developments in healthcare and biomedical analysis. This dedication is additional amplified by the collaboration with Dr. Hojae Bae, a distinguished researcher and Tethon’s bioprinting advisor. Dr. Bae Ph.D, of Konkuk College (Korea), previously of Harvard Medical College, and Clemson College, is founding father of CellBark Innovation, producer of hydrogels. He has revealed over 140 analysis papers on bio-industrial applied sciences.
“I participated in analysis that first demonstrated the cell-responsive properties of GelMA in 2010 and up to now decade my efforts have been targeted on the optimization of bioprinting platforms to attain speedy manufacturing of high-resolution and complicated 3D buildings,” provides Dr. Bae. “I’m happy to now collaborate with Tethon to speed up medical analysis.”
After the primary Bison DLP 3D printer for ceramics was launched in 2019, Tethon 3D’s Bison Bio is an R&D desktop DLP printer particularly designed for bioprinting. It the primary industrial system based mostly on DLP know-how. This versatile machine boasts absolutely adjustable settings, permitting researchers to discover the huge potential of Tethon’s supplies and even develop customized bio-materials. Priced competitively at beneath $20,000, the Bison Bio boasts options optimized for superior cell viability, making it perfect for medical, pharmaceutical, and different scientific laboratories.
GelMA scaffolds fabricated utilizing digital mild processing (DLP) 3D printing and cell viability evaluation (Unpublished Information). (A) Construction of DLP printing and printed GelMA scaffolds. Scale bar: 8 mm. (a) 4x microscope picture of the GelMA scaffold. Scale bar: 500 μm. (b) 4x fluorescence staining of the GelMA scaffold. Cells are stained with an F-actin (purple), and nuclei are stained with DAPI (blue). Scale bar: 500 μm. (c) 10x fluorescence staining of the GelMA scaffold. Cells are stained with an F-actin (purple), and nuclei are stained with DAPI (blue). Scale bar: 200 μm. (B) Fibroblast cell viability evaluation of 3D printed GelMA scaffolds on day 1, day 3, and day 5 utilizing Reside/Useless assay. Reside cells produce inexperienced fluorescence, and useless cells present purple fluorescence. Information are proven as means ± SD (n = 3). Information are analyzed by a one-way ANOVA adopted by Tukey’s post-hoc check. Scale bar: 500 μm. 
Tethon GelMA and LAP bioink are available a handy powder type, permitting for particular person or bundled purchases. Straightforward-to-follow directions information customers in mixing the bioink for optimum outcomes. Tethon’s dedication to affordability extends to GelMA, which is concentrated for enhanced cell viability and accessible in budget-friendly 2-gram portions.
“We’re desperate to discover the chances of bioprinting and empower researchers to unlock new frontiers in medical discovery, finally bettering lives,” concludes Trent Allen, Tethon 3D CEO.
The Bison Bio printer and its supporting bioinks can be found for buy now.